Cannara Biotech (TSXV:LOVE) Construction In Progress : C$4.75 Mil (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Construction In Progress?

Cannara Biotech's quarterly construction in progress increased from Aug. 2023 (C$6.81 Mil) to Nov. 2023 (C$9.10 Mil) but then declined from Nov. 2023 (C$9.10 Mil) to Feb. 2024 (C$4.75 Mil).

Cannara Biotech's annual construction in progress declined from Aug. 2021 (C$21.79 Mil) to Aug. 2022 (C$12.46 Mil) and declined from Aug. 2022 (C$12.46 Mil) to Aug. 2023 (C$6.81 Mil).

Cannara Biotech Construction In Progress Historical Data

The historical data trend for Cannara Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Construction In Progress Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Construction In Progress

Get a 7-Day Free Trial

26.57

0.09

21.79

12.46

6.81

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Construction In Progress	Get a 7-Day Free Trial															7.83	7.46	6.81	9.10	4.75

Cannara Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .